Patent · US Active

Compounds which modulate the CB2 receptor

US7595397B2 · kind B2 · utility

75Cited by

10References

4Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Renee M. Zindell · New Milford, US
Doris Riether · Biberach an der Riß, DE
David Thomson · Ridgefield, US
Eugene Richard Hickey · Danbury, US
Innocent Mushi · Felton, GB
Monika Ermann · Wantage, GB

Key dates

Filing date	Dec 8, 2006
Grant date	Sep 29, 2009
Priority date	—
Expiry date	Sep 24, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds are provided which bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, the compounds having the general formulawherein, R1, R2, A, Y, X, Ar1 and Ar2 have the meanings given in the specification, and the preparation and use thereof. The compounds are valuable CB2 receptor modulators.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.